Skip to main content
Premium Trial:

Request an Annual Quote

Berkeley Lights: John Chiminski, Gregory Lucier, Michael Marks

Berkeley Lights has named Greg Lucier as chairperson of the board of directors, effective May 14. He will succeed Michael Marks, who is retiring. John Chiminski will also join then company's board as an independent director.

Lucier is CEO of Corza Health and a former CEO of Life Technologies, acquired by Thermo Fisher Scientific in 2013. He holds an MBA from Harvard Business School.

Chiminski is CEO of pharmaceutical development and manufacturing firm Catalent, a job he has held since 2009. Prior to that, he spent more than 20 years with GE Healthcare, where he held roles including president and CEO of GE Medical Diagnostics, VP and general manager of its global magnetic resonance business, and VP and general manager of healthcare services. He holds master's degrees in electrical engineering from Purdue University and management from Northwestern University.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.